A CASE REPORT: PKP2 GENE C.1592T>G VARIATION IN HOMOZYGOUS FORM IDENTIFIED IN ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA PATIENT
AbstractArrhythmogenic right ventricular dysplasia (ARVD) is an inherited cardiomyopathy. Early recognition and follow up of this disease can reduce sudden cardiac death burden. Arrhythmogenic right ventricular dysplasia is usually inherited as an autosomal dominant trait. We report a case of a young woman aged 26 years with a past history of chest pain and palpitations. During examination, abnormalities were found in results of an electrocardiogram and echocardiography. Genetic testing of the plakophilin 2 (PKP2) gene was done by direct sequencing and genetic variation “NG_009000.1: c.1592T>G” was found in a homozygote form. In family member screening in patients, parents’ variation is found in a heterozygote form, where both are healthy. In all reports, “c.1592T>G” is reported only in a heterozygous state, with no known pathogenicity. We consider that this is possibly a pathogenic mutation, inherited as an autosomal recessive trait.
Auton A, (2015) A global reference for human genetic variation, The 1000 Genomes Project Consortium, Nature 526, 68-74,doi:10.1038/nature15393
Alcalde, M. (2014). Stop-Gain Mutations in PKP2 Are Associated with a Later Age of Onset of Arrhythmogenic Right Ventricular Cardiomyopathy. PLoS One, 26;9(6), 560.
Basso, C. (2009). Arrhythmogenic right ventricular cardiomyopathy. Lancet, 373, 1289-1300.
Corrado, D. (2015). Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Circulation, 132(5), 441-453.
Dalal, D. (2006). Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation, 113, 1641-1649.
Frank, I. (2010). Diagnosis of arrhytmogenic right ventricular cardiomyopathy/dysplasia. Proposed Modification of the Task Force Criteria. Eur Heart J., 31(7):806–814
Gerull, B. (2004). Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet, 36(11), 1162-1164.
Jain, A. (2008). Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia. J Cardiovasc Magn Reson, 10(1), 32.
LiMaura, I. E. (2013). Identification of a PKP2 gene deletion in a family with arrhythmogenic right ventricular cardiomyopathy. Eur J Hum Genet, 21(11), 1226-1231.
McNally, E. (9. January 2014). Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Načteno z PubMed: http://www.ncbi.nlm.nih.gov/books/NBK1131/
Sambrook, J. (2006). Purification of nucleic acids by extraction with phenol: chloroform. CSH Protoc, 10, 1101.
Tandri, H. (2004). Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia. J Magn Reson Imaging, 19(6), 848-858.
van der Zwaag, P. A (2009). A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy. Hum Mutat. 30(9), 1278-83.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (Creative Commons Attribution License 3.0 - CC BY 3.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
firstname.lastname@example.org, www.iseic.cz, ojs.journals.cz